Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × MCRC × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8932 Neoplasms 6858 Carcinoma, Non-Small-Cell Lung 5015 Prostatic Neoplasms 4431 Colorectal Neoplasms 4015 Lung Neoplasms 3248 Leukemia, Myeloid, Acute 2709 Neoplasm Metastasis 2702 Multiple Myeloma 2686 Pancreatic Neoplasms 2506 Melanoma 2332 Lymphoma 2274 Ovarian Neoplasms 2258 Carcinoma, Hepatocellular 2167 Stomach Neoplasms 2051 Recurrence 1943 Head and Neck Neoplasms 1831 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1818 Lymphoma, Non-Hodgkin 1805 Leukemia 1791 Brain Neoplasms 1703 Glioblastoma 1596 Colonic Neoplasms 1565 Leukemia, Lymphocytic, Chronic, B-Cell 1541 Rectal Neoplasms 1508 Uterine Cervical Neoplasms 1454 Squamous Cell Carcinoma of Head and Neck 1427 Lymphoma, Follicular 1427 Lymphoma, Large B-Cell, Diffuse 1392 Carcinoma, Renal Cell 1369

Interventions

tislelizumab 1 regorafenib 1 Trace amine-associated receptor 1 1 Thymalfasin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06829355 2025-02-17

THYMI

Beijing Friendship Hospital

Phase 2 Recruiting

MCRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡